OverviewSuggest Edit

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. The Company's medicines are helping numerous patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others.
TypePublic
Founded1887
HQNew York, US
Websitebms.com
Employee Ratings3.7

Locations

Bristol-Myers Squibb is headquartered in
New York, United States

Location Map

Latest Updates

Employees (est.) (Dec 2018)23,300(-1%)
Job Openings702
Revenue (FY, 2018)$22.6 B(+9%)
Share Price (Apr 2019)$45.5

Key People/Management at Bristol-Myers Squibb

Giovanni Caforio

Giovanni Caforio

Chairman of the Board and Chief Executive Officer
Charles Bancroft

Charles Bancroft

Executive Vice President, Chief Financial Officer and Global Business Operations
Paul Biondi

Paul Biondi

Senior Vice President, Strategy and Business Development
Adam Dubow

Adam Dubow

Senior Vice President, Chief Compliance and Ethics Officer
John Elicker

John Elicker

Senior Vice President, Corporate Affairs and Investor Relations
Ann Powell Judge

Ann Powell Judge

Senior Vice President, Chief Human Resources Officer
Show more

Bristol-Myers Squibb Office Locations

Bristol-Myers Squibb has offices in New York, Wichita, White Plains, West Palm Beach and in 181 other locations
New York, US (HQ)
345 Park Avenue, 345 Park Ave
Albany, US
Albany, NY, USA
Albuquerque, US
Albuquerque, NM, USA
Alexandria, US
Alexandria, VA, USA
Allen, US
Allen, TX, USA
Allentown, US
Allentown, PA, USA
Show all (187)

Bristol-Myers Squibb Financials and Metrics

Bristol-Myers Squibb Revenue

Bristol-Myers Squibb's revenue was reported to be $22.56 b in FY, 2018
USD

Revenue (FY, 2018)

22.6b

Net income (FY, 2018)

4.9b

Market capitalization (18-Apr-2019)

74.4b

Closing stock price (18-Apr-2019)

45.5

Cash (31-Dec-2018)

6.9b
Bristol-Myers Squibb's current market capitalization is $74.4 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

16.4b15.9b16.6b19.4b20.8b22.6b

Revenue growth, %

(3%)4%17%

Cost of goods sold

4.6b3.9b3.9b4.9b6.1b

Gross profit

11.8b11.9b12.7b14.5b14.7b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

4.1b3.8b3.9b3.9b4.0b4.2b4.1b4.4b4.9b4.9b4.9b5.1b5.3b5.2b5.7b5.7b

Cost of goods sold

1.2b968.0m991.0m1.0b847.0m1.0b1.1b1.1b1.2b1.3b1.3b1.6b1.6b1.6b1.6b1.6b

Gross profit

2.9b2.8b2.9b2.9b3.2b3.2b3.0b3.3b3.7b3.6b3.7b3.6b3.7b3.6b4.1b4.0b

Gross profit Margin, %

71%75%75%74%79%76%73%76%75%73%74%70%70%69%72%71%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

3.6b5.6b2.4b4.2b5.4b6.9b

Accounts Receivable

6.3b6.0b

Inventories

1.5b1.6b1.2b1.2b1.2b1.2b

Current Assets

18.9b14.6b10.4b13.7b14.9b17.2b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

5.2b4.3b4.9b4.2b4.0b2.6b2.9b3.4b3.9b3.5b4.6b5.3b5.0b5.4b

Accounts Receivable

3.3b3.3b3.3b3.7b3.9b5.0b5.6b5.6b5.5b5.8b5.9b5.7b5.6b5.9b

Inventories

1.7b1.7b1.6b1.3b1.1b1.3b1.4b1.5b1.4b1.2b1.3b1.2b1.2b1.3b

Current Assets

14.0b14.1b14.2b13.1b12.9b11.2b12.3b13.2b13.6b14.3b15.0b14.6b13.9b14.9b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

2.6b2.0b1.6b4.5b975.0m4.9b

Inventories

(45.0m)(254.0m)97.0m(152.0m)(29.0m)(216.0m)

Accounts Payable

412.0m(44.0m)(919.0m)104.0m320.0m(59.0m)

Cash From Operating Activities

3.5b3.1b1.8b2.9b5.3b5.9b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

1.8b936.0m1.3b2.0b1.2b1.1b1.8b1.2b2.4b3.6b1.5b2.4b3.3b1.5b1.9b3.8b

Depreciation and Amortization

465.0m

Inventories

(8.0m)(144.0m)(157.0m)(162.0m)51.0m162.0m231.0m(44.0m)(111.0m)(107.0m)(71.0m)(58.0m)7.0m(4.0m)(122.0m)

Accounts Payable

301.0m(12.0m)(112.0m)63.0m(83.0m)(618.0m)(1.2b)(77.0m)(36.0m)(142.0m)(114.0m)(85.0m)63.0m(241.0m)(101.0m)(186.0m)
USDY, 2018

Revenue/Employee

968.3k

Financial Leverage

2.5 x
Show all financial metrics

Bristol-Myers Squibb Operating Metrics

FY, 2015FY, 2016

Phase III Trials Products

2 8

Projects in R&D Pipeline

32 44
Show all operating metrics

Bristol-Myers Squibb Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
CelgeneJanuary 03, 2019$74 b

Bristol-Myers Squibb Online and Social Media Presence

Embed Graph

Bristol-Myers Squibb Frequently Asked Questions

  • When was Bristol-Myers Squibb founded?

    Bristol-Myers Squibb was founded in 1887.

  • Who are Bristol-Myers Squibb key executives?

    Bristol-Myers Squibb's key executives are Giovanni Caforio, Charles Bancroft and Paul Biondi.

  • How many employees does Bristol-Myers Squibb have?

    Bristol-Myers Squibb has 23,300 employees.

  • What is Bristol-Myers Squibb revenue?

    Latest Bristol-Myers Squibb annual revenue is $22.6 b.

  • What is Bristol-Myers Squibb revenue per employee?

    Latest Bristol-Myers Squibb revenue per employee is $968.3 k.

  • Who are Bristol-Myers Squibb competitors?

    Competitors of Bristol-Myers Squibb include Johnson & Johnson, Novartis and Eli Lilly.

  • Where is Bristol-Myers Squibb headquarters?

    Bristol-Myers Squibb headquarters is located at 345 Park Avenue, 345 Park Ave, New York.

  • Where are Bristol-Myers Squibb offices?

    Bristol-Myers Squibb has offices in New York, Wichita, White Plains, West Palm Beach and in 181 other locations.

  • How many offices does Bristol-Myers Squibb have?

    Bristol-Myers Squibb has 187 offices.